SHANG Hong-xia,SUN Wei-ming,CHENG Wei-dong,et al.Effects of Hedysarum Polybotys Saccharide on Lipid Metabolism and Expression of Stearoyl-CoA Desaturase-1 Gene in NAFLD Rats[J].zhongguo zhongyiyao xinxi zazhi,2014,21(7):47-49.[doi:10.3969/j.issn.1005-5304.2014.07.014]
红芪多糖对非酒精性脂肪肝大鼠脂代谢及硬脂酰辅酶A去饱和酶1基因表达的影响
- Title:
- Effects of Hedysarum Polybotys Saccharide on Lipid Metabolism and Expression of Stearoyl-CoA Desaturase-1 Gene in NAFLD Rats
- 文章编号:
- 1005-5304(2014)07-0047-03
- 关键词:
- 红芪多糖; 非酒精性脂肪肝; 脂代谢; 硬脂酰辅酶A去饱和酶1; 大鼠
- Keywords:
- hedysarum polybotys saccharide; NAFLD; lipid metabolism; SCD-1; rats
- 分类号:
- R285.5
- 文献标志码:
- A
- 摘要:
- 目的 观察红芪多糖对非酒精性脂肪肝(NAFLD)大鼠脂代谢及调控基因硬脂酰辅酶A去饱和酶1 (SCD-1)表达的影响,探讨其对NAFLD的干预效应。方法 受试动物按随机数字表法分为空白组和实验组,实验组采用高脂饲料喂养8周造模,随机分为模型组、阳性对照组、红芪多糖组,药物干预8周后分别检测各组大鼠血清丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)水平及三酰甘油(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-c)、低密度脂蛋白胆固醇(LDL-c)含量,采用半定量PCR检测肝脏SCD-1基因表达。结果 与空白组比较,模型组大鼠血清ALT、AST和LDL-c、TC、TG升高(P<0.05,P<0.01),HDL-c降低(P<0.01);SCD-1基因表达降低(P<0.01);与模型组比较,红芪多糖组血清ALT、AST降低(P<0.01),LDL-c、TC、TG降低(P<0.05,P<0.01),HDL-c升高(P<0.01);肝组织SCD-1基因表达升高(P<0.01)。结论 红芪多糖具有调节NAFLD大鼠脂代谢紊乱和促进调控基因SCD-1表达的作用。
- Abstract:
- Objective To investigate the effects of hedysarum polybotys saccharide (HPS) on lipid metabolism and the expression of stearoyl-CoA desaturase-1(SCD-1) gene in rats with non-alcoholic fatty liver disease (NAFLD). To discuss the interfering effects of HPS on NAFLD. Methods The SD rats were randomly divided into the blank control group and the experiment group. Rats in the experiment group were fed with lipid rich food for 8 weeks to establish model and were randomly divided into model group, drug positive group and HPS group. After 8 weeks of drug intervention, the level of ALT, AST, TC, TG, HDL-c and LDL-c were measured with automatic chemistry analyzer, and expression of SCD-1 gene was measured by semi-quantitative polymerase chain reaction. Results Compared with blank control group, serum ALT, AST and TC, TG, LDL-c of model group were higher (P<0.05, P<0.01), the level of HDL-c of model group and the expression of SCD-1 gene were lower (P<0.01). Compared with model group, HPS was useful to decrease serum ALT, AST, LDL-c, TC and TG (P<0.05, P<0.01), and increase the level of HDL-c (P<0.01) and the expression of SCD-1 gene (P<0.01). Conclusion HPS had a positive effect on regulating lipid metabolic disturbance of NAFLD rats and promoting the expression of regulatory gene SCD-1.
参考文献/References:
[1] 中华医学会肝脏病分会脂肪肝和酒精性肝病学组.非酒精性脂肪肝诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. [2] 金智生,汝亚琴,李娟娥,等.红芪多糖对实验性大鼠糖尿病胰岛素抵抗瘦素的影响[J].中西医结合心脑血管病杂志,2010,8(10):1215- 1217. [3] 蔡德丰,范建高,陆元善,等.SCD1在高脂饮食大鼠肝脏的表达及其与肝细胞凋亡的相关性[J].现代生物医学进展,2009,9(2):216-219. [4] 张介眉,时昭红,郑娅琼,等.葱神清脂软胶囊对非酒精性脂肪肝大鼠[J].中国中西医结合消化杂志,2009,4(17):217-220.
相似文献/References:
[1]郑培永,马赞颂,柳涛,等.降脂颗粒对非酒精性脂肪肝模型大鼠血清瘦素及肝脏瘦素受体mRNA的影响[J].中国中医药信息杂志,2008,15(6):36.
ZHENG Pei-yong,MA Zan-song,LIU Tao,et al.Effect of Jiangzhi Granulas on Serum Leptin and Liver Leptin Receptor mRNA of Nonalcoholic Fatty Liver Disease Rat[J].zhongguo zhongyiyao xinxi zazhi,2008,15(7):36.
[2]钱涯邻,陈维铭.芳香消脂方治疗非酒精性脂肪肝疗效观察[J].中国中医药信息杂志,2011,18(12):81.[doi:10.3969/j.issn.1005-5304.2011.12.036]
[J].zhongguo zhongyiyao xinxi zazhi,2011,18(7):81.[doi:10.3969/j.issn.1005-5304.2011.12.036]
[3]金智生,李娟娥,张东鹏,等.红芪多糖对改善2型糖尿病模型大鼠胰岛素抵抗的影响[J].中国中医药信息杂志,2007,14(5):27.
JIN Zhi-sheng,LI Juan-e,ZHANG Dong-peng,et al.Effect of Hedysarum Polybotys Saccharide on Insulin Resisance of Experimental NIDDM Rats[J].zhongguo zhongyiyao xinxi zazhi,2007,14(7):27.
[4]赵和平,段晓燕.降脂益肝冲剂对非酒精性脂肪肝大鼠肝组织PPARα及Trx mRNA表达的影响[J].中国中医药信息杂志,2007,14(7):33.
ZHAO He-ping,Duan Xiao-yan.Experimental Study of Jiangzhi Yigan Chongji on PPARα and Trx mRNA of Liver Tissue of Nonalcoholic Fatty Liver Model Rats[J].zhongguo zhongyiyao xinxi zazhi,2007,14(7):33.
[5]崔云竹,黄延芹,崔勇,等.糖肝消对糖尿病合并非酒精性脂肪肝大鼠瘦素和肿瘤坏死因子-α的影响[J].中国中医药信息杂志,2014,21(5):65.[doi:10.3969/j.issn.1005-5304.2014.05.020]
CUI Yun-zhu,HUANG Yan-qin,CUI Yong,et al.Effect of Tangganxiao on Leptin and TNF-α for NAFLD Diabetic Rats[J].zhongguo zhongyiyao xinxi zazhi,2014,21(7):65.[doi:10.3969/j.issn.1005-5304.2014.05.020]
[6]王慧英,杨蓓,李红梅.疏肝降浊汤治疗非酒精性脂肪肝60例临床观察[J].中国中医药信息杂志,2010,17(8):67.[doi:10.3969/j.issn.1005-5304.2010.08.035]
[J].zhongguo zhongyiyao xinxi zazhi,2010,17(7):67.[doi:10.3969/j.issn.1005-5304.2010.08.035]
[7]孟胜喜.壳脂胶囊治疗非酒精性脂肪肝临床研究[J].中国中医药信息杂志,2009,16(3):56.
[J].zhongguo zhongyiyao xinxi zazhi,2009,16(7):56.
[8]朱正新,唐涛,杨波.理肝化浊汤加减治疗非酒精性脂肪肝临床观察[J].中国中医药信息杂志,2008,15(6):69.
[J].zhongguo zhongyiyao xinxi zazhi,2008,15(7):69.
[9]徐慧明,王越敏,张天嵩.基于数据挖掘的非酒精性脂肪肝中医临床用药规律研究[J].中国中医药信息杂志,2014,21(8):38.[doi:10.3969/j.issn.1005-5304.2014.08.011]
XU Hui-ming,WANG Yue-min,ZHANG Tian-song.Data Mining of Regularities and Rules of Compound Herbal Formulae for Nonalcoholic Fatty Liver Disease[J].zhongguo zhongyiyao xinxi zazhi,2014,21(7):38.[doi:10.3969/j.issn.1005-5304.2014.08.011]
[10]李世杰,翟宏伟.消脂康配方颗粒治疗非酒精性脂肪肝临床研究[J].中国中医药信息杂志,2015,22(8):22.[doi:10.3969/j.issn.1005-5304.2015.08.007]
LI Shi-jie,ZHAI Hong-wei.Clinical Study on Xiaozhikang Formula Granules for the Treatment of Nonalcoholic Fatty Liver Disease[J].zhongguo zhongyiyao xinxi zazhi,2015,22(7):22.[doi:10.3969/j.issn.1005-5304.2015.08.007]
备注/Memo
基金项目:甘肃省中医药管理局资助项目(GZK-2012-65)
更新日期/Last Update:
2014-06-12